Product Detail
Dextran (Technical Grade~ 10K)
Carbohydrates
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Carbohydrates
API Family
--
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Dextran (Technical Grade~ 10K) Product Information
Dextran (Technical Grade~ 10K) is listed under Carbohydrates. It is associated with - and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-16697.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Dextran (Technical Grade~ 10K)
CAS No.
9004-54-0
CAT No.
CS-T-16697
Molecular Formula
C17H32O10
Molecular Weight
396.43
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
(2R,3S,4R,5R,6R)-2-((((2R,3S,4S,5R,6R)-3,5-dihydroxy-4-methoxy-6-(methoxymethyl)tetrahydro-2H-pyran-2-yl)methoxy)methyl)-6-ethyltetrahydro-2H-pyran-3,4,5-triol; 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
A polysaccharide composed of glucose molecules used as an antithrombotic to reduce blood viscosity and as a volume expander in anemia. Studies show that it inhibits the mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA).
Synonyms
Dextran (Technical Grade~ 10K); (2R,3S,4R,5R,6R)-2-((((2R,3S,4S,5R,6R)-3,5-dihydroxy-4-methoxy-6-(methoxymethyl)tetrahydro-2H-pyran-2-yl)methoxy)methyl)-6-ethyltetrahydro-2H-pyran-3,4,5-triol
Application Notes
A polysaccharide composed of glucose molecules used as an antithrombotic to reduce blood viscosity and as a volume expander in anemia. Studies show that it inhibits the mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA).
References
"MacNeil, B,D, et al,: Fund, Clin, Cardiol,, 52, 473 (2005); Noorman, F, et al,: Thromb, Haemost,, 80, 210 (1998); Fushbane, S, et al,: Am, J, Kidney Dis,, 28, 529 (1996);"